Christine Nguyen
Podiatrist · Sugar Land, TXNPI 1396127767
Payments from drug & device makers
Across 136 payments — averaging $57.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$5K
- Musculoskeletal Transplant Foundation Inc.$987
- Smith+Nephew$338
- Treace Medical Concepts, Inc.$220
- Biocomposites Inc$155
- Amgen$140
- plus $954 from 16 others
What the payments were for
- Travel & lodging$1,34317%
- Food & beverage$6,43482%
- Education$260%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 88 | $5,010 |
| Musculoskeletal Transplant Foundation Inc. | 4 | $987 |
| Smith+Nephew | 11 | $338 |
| Treace Medical Concepts, Inc. | 2 | $220 |
| Biocomposites Inc | 2 | $155 |
| Amgen | 2 | $140 |
| Boston Scientific | 1 | $140 |
| Osiris Therapeutics Inc. | 5 | $133 |
| Cardiovascular Systems Inc. | 1 | $113 |
| W. L. Gore & Associates, Inc. | 1 | $94 |
| Biotissue Holdings Inc. | 1 | $70 |
| Alafair Biosciences, Inc. | 1 | $62 |
| Fidia Pharma USA Inc. | 3 | $52 |
| Hartmann USA, Inc. | 2 | $50 |
| Genentech USA, Inc. | 2 | $48 |
| KCI USA, Inc. | 1 | $38 |
| Integra Lifesciences Corporation | 2 | $31 |
| Assertio Therapeutics, Inc. | 2 | $31 |
| Pacira Pharmaceuticals Incorporated | 1 | $24 |
| Amniox Medical, Inc. | 1 | $24 |
| Heron Therapeutics, Inc. | 1 | $23 |
| Kerecis Limited | 2 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MAKO$782
- HOFFMANN$721
- ALLOWRAP$645
- FIXOS$171
- VARIAX$166
- ALLOGRAFT$163
- Stimulan$143
- ANCHORAGE$142
- ELUVIA$140
- ASNIS$127
- KRYSTEXXA$125
- Lapiplasty System$124
- REGRANEX$123
- COLLAGENASE SANTYL$122
- Diamondback Peripheral$113
How this compares
$7,803 in reported general payments places this provider in the 80th percentile of 470 podiatrist providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 79 | $1,308 |
| Ciclopirox | 42 | $1,107 |
| Mupirocin | 130 | $958 |
| Diclofenac Sodium | 32 | $574 |
| Gentamicin Sulfate | 17 | $433 |
| Doxycycline Monohydrate | 43 | $385 |
| Ketoconazole | 35 | $323 |
| Clotrimazole | 13 | $221 |
| Cephalexin | 33 | $116 |
| Meloxicam | 42 | $89 |
| Silver Sulfadiazine | 18 | $87 |
| Ciprofloxacin Hcl | 14 | $86 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 28 | $80 |
| SsdSilver Sulfadiazine | 11 | $69 |
| Naproxen | 16 | $66 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Sugar Land
- Porsha MelcherSugar Land$14K
- Brian CarpenterFort Worth$1.2M
- Gary LepowHouston$1M
- Travis MotleyFort Worth$888K
- Wayne HurstCedar Park$625K
- Calvin RushingSunnyvale$462K
- Lena LevineFort Worth$298K
- Robert TaylorFrisco$280K
- Alan GarrettFort Worth$236K
- Patrick BriggsWebster$236K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.